The North American CFRD Guidelines Committee endorses OGTT over fasting BGL and HbA1c because of its superior accuracy, its association with nutritional and pulmonary deterioration, and its ability to facilitate early insulin treatment to prevent CF‐ and diabetes‐related complications [71]. This evidence concerns the gene INS and cystic fibrosis.